Navigation Links
Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010
Date:11/3/2010

RICHMOND, Va., Nov. 3, 2010 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, today reported results for the third quarter and nine-months ended September 30, 2010.

Total revenues for the third quarter ended September 30, 2010 were $1.8 million, as compared to $2.5 million for the corresponding period in 2009.  The $0.7 million decline in revenue was entirely due to lower cost recovery in the most recent quarter from our IPLEX™ Expanded Access Program ("EAP") in Italy for the treatment of Amyotrophic Lateral Sclerosis ("ALS").  In 2009, the Company ceased patient enrollment in the EAP in order to preserve inventory for existing patients.Net loss for the third quarter of 2010 was $0.3 million, break even on a per share basis, compared with a net loss of $0.1 million, also break even on a per share basis, reported in the third quarter of 2009.  The $0.2 million change in net loss was primarily due to the $0.7 million decrease in revenues, noted above, and a $0.3 million decrease in investment income, which were largely offset by an overall reduction of $0.8 million in operating expenses.

The $0.8 million decrease in total expenses resulted from a $0.3 million reduction in research and development expenses ("R&D expenses") and a $0.5 million decline in selling, general and administrative expenses ("SG&A expenses").  The lower R&D expenses resulted largely from the elimination of IPLEX™ fill-finish costs which we incurred in the third quarter of 2009, while the reduced SG&A expenses were principally due to lower external market research and consultancy fees associated with our ongoing strategic review process.

Investment income for the 2010 third quarter was $345,000, as compared to $682,000 for the same period in 2009; as overall market returns declined in the current quarter versus
'/>"/>

SOURCE Insmed Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Insmed to Host Third Quarter 2010 Conference Call
2. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
3. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
4. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
5. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
6. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
7. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
8. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
9. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
10. Uroplasty Inc. Announces CPT® Category I Code and Associated Reimbursement Value for Posterior Tibial Nerve Stimulation
11. Hanger Orthopedic Group, Inc. Announces Early Tender Results of Offer to Purchase Outstanding 10-1/4% Senior Notes Due 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... CHAPEL HILL, N.C. , Aug. 29, 2014 /PRNewswire/ ... Opinion Leaders (KOLs) can be the difference between a ... struggle to effectively map and stratify KOL targets – ... to build the type of strong relationships upon which ... recent research, savvy pharma companies have identified internal inconsistencies ...
(Date:8/29/2014)... Ore. , Aug. 29, 2014 /PRNewswire-iReach/ -- ... Accessory (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today ... voluntary recall to address a potential issue with ... used for the Axilla application of the SAM ...
(Date:8/29/2014)... MARLBOROUGH, Mass. , Aug. 29, 2014 /PRNewswire/ ... ) prospective, multinational study on stent removability and ... strictures has been published in the August issue ... The multinational study 1 is being conducted ... removal of fully covered self-expanding metal stents (FCSEMS) ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... COLUMBUS and ZANESVILLE, Ohio , May ... www.huntington.com ) has created a unique funding model to finance ... installation at one of the region,s largest health care providers, ... equipment finance deal will install a clinical information system ...
... YORK , May 12 Reportlinker.com announces that a new market research report is ... Ophthalmic Therapeutic Drugs: Technologies and Global Markets ... http://www.reportlinker.com/p0196569/Ophthalmic-Therapeutic-Drugs-Technologies-and-Global-Markets.html , , ... , , ...
Cached Medicine Technology:Huntington Financing Package Supports Major Regional Medical Center Electronic Medical Records Project 2Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 2Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 3Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 4Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 5Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 6Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 7Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 8Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 9Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 10Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 11Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 12Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 13Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 14Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 15Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 16Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 17Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 18Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 19Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 20Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 21Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 22Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 23Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 24Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 25
(Date:8/31/2014)... 31, 2014 MYMOBILEUNI (MMU) strategy ... social media marketing tools access to digital, resources, ... will utilize all tools to reach and collaborate ... our multiple learning channels. , MMU, today announced ... an authoring tool that applies social networking concepts ...
(Date:8/31/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... of bamboo veneers . Additionally, it has deiced offer ... high quality products. The promotion will last from today until ... its top quality veneers are hot in the global market. ... bamboo veneers. All these items are made according to our ...
(Date:8/31/2014)... LabDoor.com tests the purity and label accuracy ... their website, “We buy products in the same fashion ... online sites. No manufacturer-supplied samples are permitted at LabDoor.” ... LabDoor,” a recent study was performed on twenty of ... United States for Vitamin D3 content, heavy metal contamination, ...
(Date:8/31/2014)... 01, 2014 Top10BestSEOHosting.com, a reliable review ... and announces that FatCow, Arvixe and Hostgator are the ... plenty of ASP.NET hosting companies in the world, but ... complicated to run a reliable ASP.NET server than running ... skills. I firmly believe that FatCow, Arvixe and Hostgator ...
(Date:8/31/2014)... 01, 2014 UWDress.com, a renowned wedding ... a new range of elegant formal bridesmaid dresses ... promotion for its high quality special occasion outfits. All ... (up to 65% off). , Along with the ... free gifts. The company’s promotional formal bridesmaid outfits are ...
Breaking Medicine News(10 mins):Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 4Health News:Best ASP.NET Hosting Award for August 2014 Released By Top10BestSEOHosting.com 2Health News:Elegant Formal Bridesmaid Dresses Today Unveiled By UWDress.com 2
... University of Wisconsin-Madison Center of Excellence in Cancer Communications Research ... Breast cancer patients who pray in online support groups can ... many cancer patients pray in online support groups to help ... we are aware of that examines the psychological effects of ...
... to alleviate symptoms of early-stage Parkinson's disease, and may ... manage the brain disorder,// researchers said., ,A neupro ... used to study its effects on 277 people in ... patch is designed to convey a drug called ...
... a customised personal digital assistant (PDA) to dramatically ... said Thursday. ,Instead of fumbling with ... speech impairments express their needs in such everyday ... attention from an archive of commonly-used phrases and ...
... regarded as a psychological disorder. Dr Sabine Nissan from Karolinska ... Sweden. ,The researchers found out that a third ... suffer from other metabolic disorders. The study points of that ... imbalance. The patients may often be overeating due to hormonal ...
... suggests a link between a particular gene named ApoE-4 ... Neurobiology of Aging, published the results of the research. ... in causing Alzheimer’s disease. ,This research now is ... the possibility that occurrence of herpes infection earlier in ...
... may have a greater risk of getting prostate cancer, according ... families of men diagnosed with prostate cancer with other men ... cancer were related. ,The Journal of the National ... the factors responsible for prostate cancer and having more daughters ...
Cached Medicine News:Health News:Online Prayers Helps Cancer Patients 2Health News:Excessive Male Hormones can Cause Bulimia in Women 2Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 2Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 3Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 4Health News:Gender Of Children May Be Linked To Risk Of Prostate Cancer 2
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The link ribbed hip stem for cementless primary hip replacement surgery....
The cemented hip joint prosthesis system....
The Quatroloc primary hip system offers 35 primary stems to fit almost all femurs for primary hip arthroplasty....
Medicine Products: